Axsome Therapeutics Statistics
Total Valuation
AXSM has a market cap or net worth of $12.02 billion. The enterprise value is $11.94 billion.
Important Dates
The last earnings date was Monday, May 4, 2026, before market open.
| Earnings Date | May 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AXSM has 51.46 million shares outstanding. The number of shares has increased by 4.24% in one year.
| Current Share Class | 51.46M |
| Shares Outstanding | 51.46M |
| Shares Change (YoY) | +4.24% |
| Shares Change (QoQ) | +1.12% |
| Owned by Insiders (%) | 1.11% |
| Owned by Institutions (%) | 76.63% |
| Float | 43.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.98 |
| Forward PS | 10.70 |
| PB Ratio | 220.09 |
| P/TBV Ratio | 3,341.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 4.03.
| Current Ratio | 1.39 |
| Quick Ratio | 1.27 |
| Debt / Equity | 4.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.83 |
Financial Efficiency
Return on equity (ROE) is -349.38% and return on invested capital (ROIC) is -40.95%.
| Return on Equity (ROE) | -349.38% |
| Return on Assets (ROA) | -16.84% |
| Return on Invested Capital (ROIC) | -40.95% |
| Return on Capital Employed (ROCE) | -64.33% |
| Weighted Average Cost of Capital (WACC) | 7.42% |
| Revenue Per Employee | $580,521 |
| Profits Per Employee | -$154,347 |
| Employee Count | 1,220 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 2.19 |
Taxes
| Income Tax | -530,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +115.64% in the last 52 weeks. The beta is 0.58, so AXSM's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +115.64% |
| 50-Day Moving Average | 188.36 |
| 200-Day Moving Average | 156.05 |
| Relative Strength Index (RSI) | 72.15 |
| Average Volume (20 Days) | 916,251 |
Short Selling Information
The latest short interest is 2.75 million, so 5.34% of the outstanding shares have been sold short.
| Short Interest | 2.75M |
| Short Previous Month | 2.68M |
| Short % of Shares Out | 5.34% |
| Short % of Float | 6.31% |
| Short Ratio (days to cover) | 3.89 |
Income Statement
In the last 12 months, AXSM had revenue of $708.24 million and -$188.30 million in losses. Loss per share was -$3.74.
| Revenue | 708.24M |
| Gross Profit | 655.82M |
| Operating Income | -176.53M |
| Pretax Income | -188.83M |
| Net Income | -188.30M |
| EBITDA | -167.23M |
| EBIT | -176.53M |
| Loss Per Share | -$3.74 |
Full Income StatementBalance Sheet
The company has $305.11 million in cash and $219.90 million in debt, with a net cash position of $85.21 million or $1.66 per share.
| Cash & Cash Equivalents | 305.11M |
| Total Debt | 219.90M |
| Net Cash | 85.21M |
| Net Cash Per Share | $1.66 |
| Equity (Book Value) | 54.59M |
| Book Value Per Share | 1.06 |
| Working Capital | 172.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$70.73 million and capital expenditures -$263,000, giving a free cash flow of -$70.99 million.
| Operating Cash Flow | -70.73M |
| Capital Expenditures | -263,000 |
| Depreciation & Amortization | 9.30M |
| Net Borrowing | -4.38M |
| Free Cash Flow | -70.99M |
| FCF Per Share | -$1.38 |
Full Cash Flow StatementMargins
Gross margin is 92.60%, with operating and profit margins of -24.93% and -26.59%.
| Gross Margin | 92.60% |
| Operating Margin | -24.93% |
| Pretax Margin | -26.66% |
| Profit Margin | -26.59% |
| EBITDA Margin | -23.61% |
| EBIT Margin | -24.93% |
| FCF Margin | n/a |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.24% |
| Shareholder Yield | -4.24% |
| Earnings Yield | -1.57% |
| FCF Yield | -0.59% |
Analyst Forecast
The average price target for AXSM is $270.28, which is 15.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $270.28 |
| Price Target Difference | 15.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 26.96% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXSM has an Altman Z-Score of 3.81 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.81 |
| Piotroski F-Score | 4 |
